Idamycin

Idamycin

 [i″dah-mi´sin]
trademark for a preparation of idarubicin, an antitumor antibiotic.
Mentioned in ?
References in periodicals archive ?
Kaposi's sarcoma; Idamycin (idarubicin hydrochloride), approved in
The Drug Innovation Paradox
Last November, Israel's Teva Pharmaceutical Industries Ltd., the world's biggest generic drugmaker, said it would pay Pfizer as much as $70 million for rights to make copies of Zithromax and the cancer drug Idamycin.
Pfizer settles Zithromax patent suit with Novartis
In the first 6 months of 1997, the following new drugs were approved by the FDA: Agrylin, Alesse, Anzemet, Carbatrol, Fareston, Flomax, Galzin, Idamycin, Migranal, Posicor, Prelay, Prevacid, Pytest, Requip, Resulin, Serlect, Skelid, Tasmar, Uniretic, Urso, Vicoprofen, Viracept, Zyban.
Supporting pharmaceutical studies for FDA submissions: diversifying the drug monitoring laboratory

Medical browser ?
Full browser ?